Zvogra 120 mg solution for injection
Authorisation EU/1/25/1981/001-003 · Stada Arzneimittel AG
- Licence holder
- Stada Arzneimittel AG (all products →)
- Active substance
- Denosumab
- Clinical trials
- 24 clinical trials →
- Dosage form
- Solution for injection
- Route of administration
- Subcutaneous use
- ATC code
- M05BX04
- First authorised
- 17/11/2025
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Similar biological application (Article 10(4) of Directive No 2001/83/EC)
Denosumab: supply and approvals
33 authorised products on the HPRA list contain Denosumab. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 18 Nov 2026)
- Recent EMA authorisation
- Denosumab Ascend, 28 Aug 2026 (biosimilar), Ascend GmbH
Osqay, 8 Jan 2026 (biosimilar), Theramex Ireland Limited
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 1981. It has been authorised for 1 year (since 17 November 2025). The HPRA list does not say whether it is on sale.
Other medicines with Denosumab in Ireland
32 other products on the HPRA list contain Denosumab, from 17 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Acvybra 60 mg solution for injection in pre-filled syringe | Reddy Holding GmbH | Centralised EU authorisation | Not stated |
| BOMYNTRA 120 mg solution for injection in pre-filled syringe | Fresenius Kabi Deutschland GmbH | Centralised EU authorisation | Not stated |
| BOMYNTRA 120 mg solution for injection in vial | Fresenius Kabi Deutschland GmbH | Centralised EU authorisation | Not stated |
| Bildyos 60 mg solution for injection | Sciencepharma Sp. z o.o. | Centralised EU authorisation | Not stated |
| Bildyos 60 mg solution for injection in pre-filled syringe | Sciencepharma Sp. z o.o. | Centralised EU authorisation | Not stated |
| Bilprevda 120 mg solution for injection | Henlius Europe GmbH | Centralised EU authorisation | Not stated |
| Conexxence 60 mg solution for injection in pre-filled syringe | Fresenius Kabi Deutschland GmbH | Centralised EU authorisation | Not stated |
| Degevma 120 mg solution for injection | TEVA GmbH | Centralised EU authorisation | Not stated |
| Denbrayce 120 mg solution for injection | Mabxience Research, S.L. | Centralised EU authorisation | Not stated |
| Enwylma 120 mg solution for injection | Zentiva k.s. | Centralised EU authorisation | Not stated |
| Evfraxy 60 mg solution for injection in pre-filled syringe | Biosimilar Collaborations Ireland Limited | Centralised EU authorisation | Not stated |
| Izamby 60 mg solution for injection in pre-filled syringe | Mabxience Research, S.L. | Centralised EU authorisation | Not stated |
The licence holder
Stada Arzneimittel AG holds 45 products on the HPRA list, with 17 different active substances; 3 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.